Generally, chemotherapy drugs work by targeting [...]]]> There are three traditional kinds of treatment for patients with malignant mesothelioma: Surgery (taking out the cancer), chemotherapy (using drugs to fight the cancer), and radiation therapy (using high-dose x-rays or other high-energy rays to kill cancer cells). This article focuses on the use of chemotherapy to treat mesothelioma.

Generally, chemotherapy drugs work by targeting specific processes in cells that are undergoing rapid division and growth, preventing cell division, resulting in the death of the cancerous cells. Because in the past surgery alone has failed to effect a cure, or even to help prolong life for any extended period of time, it is currently being combined with traditional chemotherapy and/or radiation, or other new approaches such as gene therapy, immunotherapy or photodynamic therapy.

Since chemotherapy for mesothelioma is not considered “curative”, the goal is to control the cancer by stopping its spread or slowing its growth. The most common use for chemotherapy in mesothelioma patients is as an option for those who are not surgical candidates. However, cancer centers are conducting trials using the neoadjuvant approach (giving chemotherapy before surgery). The most common way to administer chemotherapy is intravenously, or through a vein.

Intraperitoneal chemotherapy may also be delivered through a catheter or a port. In general, chemotherapy treatment is administered in “cycles”. A “cycle” being defined as a period of treatment followed by a period of rest. The number of treatment cycles, or the length of time between the beginning and end of chemotherapy may vary. In general, 3 to 4 cycles of treatment are given before response is evaluated and 2 to 3 cycles are considered a minimum to assess for effectiveness.

After response to the treatment has been determined, the following criteria will be used to decide whether chemotherapy should continue:

1. If there is shrinkage of the tumor, or the disease is kept stable, chemotherapy may be continued for as long as it can be tolerated and there is no disease progression.

2. If there is continued disease progression, chemotherapy will be stopped, and the patient will be given alternative options.

One of the most common side effects, and one your doctor will monitor carefully, is a chemotherapy-induced low white blood cell count (neutropenia) which means your immune system is weakened, therefore leaving you more prone to infection. While this side effect is anticipated when someone is undergoing chemotherapy, it can cause delays in your treatment schedule, or changes in the dosage of the drugs you will receive.

Most chemotherapy drugs have specific side effects such as nausea, vomiting, loss of appetite, hair loss, and increased vulnerability to infection. Understanding the various chemotherapy options and available treatments often helps patients and their loved ones make the best decision for their personal situation.

Deciding which chemotherapy option is the best treatment for specific mesothelioma cases depends on a number of factors, including the type of mesothelioma, the stage of the disease, and other treatment being administered. Factors such as overall physical health and age are also taken into consideration when detailing a chemotherapy treatment plan. Many mesothelioma patients will consider chemotherapy as a treatment option.

Find More Mesothelioma Patient Articles

Product DescriptionInflammatory bowel disease (IBD) is an increasing problem from a population health point of view, and novel approaches in diagnostics and therapeutics are rapidly evolving. IBD has also emerged as an important example of a complex chronic inflammatory disease where genetics, environmental risk factors, and individual phenotypic expression of disease interact to establish [...]]]>

Product Description
Inflammatory bowel disease (IBD) is an increasing problem from a population health point of view, and novel approaches in diagnostics and therapeutics are rapidly evolving. IBD has also emerged as an important example of a complex chronic inflammatory disease where genetics, environmental risk factors, and individual phenotypic expression of disease interact to establish patterns of disease and potential disease etiologies. In fact, the recent description of a gene specific for Crohn’s disease (NOD2), the exploration of the role of microbes in disease causation, and the harnessing of microbes therapeutically (such as with probiotics) have facilitated the emergence of IBD as an important model amongst the chronic inflammatory diseases. This Yearbook is the first in an annual series, providing clinicians and scientists with state-of-the-art updates on the hot topics relevant to clinical practice and to IBD research.

The Inflammatory Bowel Disease Yearbook 2003

Product DescriptionOver the last 50 years, tremendous strides have been made in the treatment of congenital heart disease. Many patients with congenital heart disease are now reaching adulthood and seeking medical care from cardiologists, internists, and family practitioners who do not historically deal with congenital heart disease. Written by two acclaimed authorities and educators [...]]]>

Product Description
Over the last 50 years, tremendous strides have been made in the treatment of congenital heart disease. Many patients with congenital heart disease are now reaching adulthood and seeking medical care from cardiologists, internists, and family practitioners who do not historically deal with congenital heart disease. Written by two acclaimed authorities and educators in the field, Jesse E. Edwards’ Synopsis of Congenital Heart Disease provides these physicians with a richly illustrated refresher course, and a handy reference text, in the fundamentals of congenital heart disease.

In this book, Dr. Jesse Edwards shares his vast experience in a discussion of the fundamental anatomy and physiology associated with congenital heart disease. The text provides succinct descriptions of the common and uncommon abnormalities of congenital heart disease and the principles underlying their treatment, while 200 figures clearly demonstrate and guide the user to understand the essential nature of the characteristic defects and abnormalities discussed.

This book will serve as a unique and useful reference to broaden the knowledge of adult cardiologists, internists, radiologists, cardiovascular nurses, nurse practitioners, cardiac catheterization personnel, and other paramedical professionals who wish to understand more thoroughly the fundamentals of congenital heart disease.

Jesse E. Edwards’ Synopsis of Congenital Heart Disease

Product DescriptionThe Congenital Heart Disease Ribbon proudly displayed on a tile trivet. There is no [...]]]>

• Ceramic Tile Trivet
• Great Gift – Great Quality – Imprinted in The USA
• 4.25″ x 4.25″ x .25″
• Can be used as a coaster, tile trivet, hot plate, or decorative piece
• High Gloss Finish, High Quality with Lasting Durability

Product Description
The Congenital Heart Disease Ribbon proudly displayed on a tile trivet. There is no better way to achieve awareness for the Congenital Heart Disease Ribbon than to display it on a tile for everyone to see. The Congenital Heart Disease Ribbon Tile measures approximately at 4.25 x 4.25 x .25 inches. Start gaining awareness today by presenting your Congenital Heart Disease Ribbon tile at work or at home. This tile is great to be used for a tile trivet for hot plates, coaster, a decorative table piece or as a back splash for a kitchen, bathroom or anywhere that is being tiled.

Congenital Heart Disease Awareness Ribbon Tile Trivet

Product DescriptionPacked with practical advice on disease education, lifestyle management and emotional support from children, parents and the medical experts at Children’s Hospital Boston, this DVD, “Growing up with Crohn’s Disease: What Every Family Should Know” is [...]]]>

• 12 Modules that covers everything from medication to research
• Printable summary points
• Over 1 hour in length

Product Description
Packed with practical advice on disease education, lifestyle management and emotional support from children, parents and the medical experts at Children’s Hospital Boston, this DVD, “Growing up with Crohn’s Disease: What Every Family Should Know” is designed to empower families with child facing Crohn’s disease. Based on real-life experiences, it is the first step in helping children with Crohn’s disease live life to the fullest.
“Through clear medical explanations and personal stories, this superb video from Children’s Hospital Boston conveys what every family should learn about Crohn’s disease.” Bruce Sands, MD, Medical Co-Director MGH Crohn’s and Colitis Center

Children’s Hospital Boston Family Health Education Series- Growing up with Crohn’s Disease: What Every Family Should Know